$9.980
0.000 (0.00%)收盤時
- 最高
- 9.980
- 開盤
- 9.980
- 成交量加權均價
- 9.98
- 成交量
- 20.00
- 市值
- —
- 最低
- 9.980
- 成交金額
- 199.60
- 企業價值/稅息折舊攤銷前利潤(TTM)
- 0.00
Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.
AI 分析 of Rainier Acquisition Corporation Class A Ordinary Shares (RNAQ)
賣出Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.
估值指標
事件時間軸
RNAQ 常見問題 —— 由 Alphio AI 解答
Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.
Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.
社群
更多 ↗暫無貼文
註冊或登入後參與討論相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。